On April 25, 2024, the company announced that it has extended its plan duration till February 5, 2025.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.75 CNY | -2.45% | -7.36% | -8.63% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.63% | 1.54B | |
+38.03% | 705B | |
+32.82% | 583B | |
-3.55% | 364B | |
+20.26% | 332B | |
+5.28% | 291B | |
+17.25% | 238B | |
-3.68% | 210B | |
+10.51% | 209B | |
+8.51% | 169B |
- Stock Market
- Equities
- 600557 Stock
- News Jiangsu Kanion Pharmaceutical Co.,Ltd.
- Jiangsu Kanion Pharmaceutical Co.,Ltd. Equity Buyback Plan Extended till February 5, 2025.